trending Market Intelligence /marketintelligence/en/news-insights/trending/729Vq35lFznicluxQzh1zA2 content esgSubNav
In This List

Eleven Biotherapeutics plans common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Eleven Biotherapeutics plans common stock offering

Eleven Biotherapeutics Inc. plans to offer $12.5 million of its common stock.

The company plans to use the net proceeds to continue funding the clinical development of Vicinium and for general corporate purposes, which may include capital expenditures and funding our working capital needs.

H.C. Wainwright & Co. LLC will act as the sole book-running manager for this offering.